Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Shares Outstanding (Diluted Average): 2019-2025

Historic Shares Outstanding (Diluted Average) for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $58.7 million.

  • Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) rose 1.09% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 1.09%. This contributed to the annual value of $57.9 million for FY2024, which is 4.15% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Shares Outstanding (Diluted Average) of $58.7 million as of Q3 2025, which was up 0.46% from $58.5 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) registered a high of $61.2 million during Q1 2023, and its lowest value of $57.6 million during Q2 2024.
  • Over the past 3 years, Harmony Biosciences Holdings' median Shares Outstanding (Diluted Average) value was $58.5 million (recorded in 2025), while the average stood at $59.1 million.
  • In the last 5 years, Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) soared by 654.82% in 2021 and then fell by 5.92% in 2024.
  • Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) (Quarterly) stood at $59.2 million in 2021, then increased by 3.20% to $61.1 million in 2022, then declined by 1.19% to $60.4 million in 2023, then fell by 4.15% to $57.9 million in 2024, then increased by 1.09% to $58.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $58.7 million for Q3 2025, versus $58.5 million for Q2 2025 and $58.5 million for Q1 2025.